Share this page:
Featured News
Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
March 13, 2019
WASHINGTON — Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson’s disease demonstrates precisely how the agent increases levels of dopamine in the brains of study participants, says a research team at Georgetown University Medical Center. Symptoms of Parkinson’s, such as motor dysfunction, Read More »
